These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 4040993)

  • 1. Diurnal profiles of plasma cholecystokinin (CCK) and vasoactive intestinal polypeptide (VIP) in man.
    Burhol PG; Lygren I; Jenssen TG; Jorde R
    Mater Med Pol; 1985; 17(1):30-3. PubMed ID: 4040993
    [No Abstract]   [Full Text] [Related]  

  • 2. Ageing and the diurnal expression of mRNAs for vasoactive intestinal peptide and for the VPAC2 and PAC1 receptors in the suprachiasmatic nucleus of male rats.
    Kalló I; Kalamatianos T; Piggins HD; Coen CW
    J Neuroendocrinol; 2004 Sep; 16(9):758-66. PubMed ID: 15344914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diurnal profiles of gastrointestinal regulatory peptides.
    Jorde R; Burhol PG
    Scand J Gastroenterol; 1985 Jan; 20(1):1-4. PubMed ID: 2859649
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of psychological stress on small intestinal motility and expression of cholecystokinin and vasoactive intestinal polypeptide in plasma and small intestine in mice.
    Cao SG; Wu WC; Han Z; Wang MY
    World J Gastroenterol; 2005 Feb; 11(5):737-40. PubMed ID: 15655834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Secretin and cholecystokinin: hormonal action on the concentration of vasoactive intestinal polypeptide and gastrin in human subjects?].
    Bauer FE; Schulz E; von Kleist D; Janisch HD; Hampel KE
    Z Gastroenterol; 1984 Aug; 22(8):388-93. PubMed ID: 6485438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in plasma levels of cholecystokinin, neurotensin, VIP and PYY in gastric and colorectal cancer - Preliminary results.
    Zygulska AL; Furgala A; Kaszuba-Zwoińska J; Krzemieniecki K; Gil K
    Peptides; 2019 Dec; 122():170148. PubMed ID: 31541684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lunch induces an increase in the plasma prolactin concentration, but not vasoactive intestinal peptides or cholecystokinin.
    Miyake A; Yoshimoto Y; Kawamura Y; Aono T; Tanizawa O; Shinomura Y; Himeno S; Tarui S
    Endocrinol Jpn; 1988 Aug; 35(4):647-50. PubMed ID: 3215151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of gut hormones with irritable bowel syndrome.
    Zhang H; Yan Y; Shi R; Lin Z; Wang M; Lin L
    Digestion; 2008; 78(2-3):72-6. PubMed ID: 18948690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioimmunoassay of plasma cholecystokinin (CCK), duodenal release of CCK, diurnal variation of plasma CCK, and immunoreactive plasma CCK components in man.
    Burhol PG; Rayford PL; Jorde R; Waldum HL; Schulz TB; Thompson JC
    Hepatogastroenterology; 1980 Aug; 27(4):300-9. PubMed ID: 7193631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Release of gastrointestinal regulatory peptides after a soap enema.
    Jenssen TG; Burhol PG; Jorde R
    Scand J Gastroenterol; 1985 Aug; 20(6):762-6. PubMed ID: 2863869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of duodenal infusion of graded doses of HCL on plasma secretin and vasoactive intestinal polypeptide (VIP), and on duodenal bicarbonate secretion in man.
    Lygren I; Burhol PG; Waldum HL; Jorde R
    Mater Med Pol; 1980; 12(4):223-8. PubMed ID: 7266047
    [No Abstract]   [Full Text] [Related]  

  • 12. Vasoactive intestinal polypeptide (VIP) plasma levels in chronic renal failure.
    Piga M; Altieri P; Floris A; Barraca A; Tagleri G; Madeddu G; Bolasco F; Gervasi F; Piras MR; Serra AR
    J Nucl Med Allied Sci; 1984; 28(2):77-80. PubMed ID: 6512602
    [No Abstract]   [Full Text] [Related]  

  • 13. Daily and circadian expression of neuropeptides in the suprachiasmatic nuclei of nocturnal and diurnal rodents.
    Dardente H; Menet JS; Challet E; Tournier BB; Pévet P; Masson-Pévet M
    Brain Res Mol Brain Res; 2004 May; 124(2):143-51. PubMed ID: 15135222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasoactive intestinal peptide fluctuates in human blood with a circadian rhythm.
    Cugini P; Lucia P; Di Palma L; Re M; Leone G; Battisti P; Canova R; Gasbarrone L; Cianetti A
    Regul Pept; 1991 Jul; 34(3):141-8. PubMed ID: 1924885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropeptide chronomics in clinically healthy young adults: circaoctohoran and circadian patterns.
    Löckinger A; Köberle D; König PS; Saria A; Herold M; Cornélissen G; Halberg F
    Peptides; 2004 Apr; 25(4):533-42. PubMed ID: 15165707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diurnal and seasonal variation of cholecystokinin peptides in humans.
    Lundberg K; Josefsson A; Nordin C
    Neuropeptides; 2007 Feb; 41(1):59-63. PubMed ID: 17208296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioimmunoassay for vasoactive intestinal polypeptide (VIP) in plasma before and during endoscopic examinations.
    Hossdorf T; Burger M; Burger M; Karoff C; van Husen N; Wagner H
    Hepatogastroenterology; 1982 Aug; 29(4):146-50. PubMed ID: 7129338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of cholecystokinin and vasoactive intestinal peptide on locomotion and rearing in neofrontal decorticated rats.
    Katsuura G; Itoh S
    Prog Clin Biol Res; 1985; 192():147-50. PubMed ID: 4080707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasoactive intestinal peptide is a biorhythmic variable of human blood.
    Cugini P; Re M; Leone G; Di Palma L; Canova R; Gasbarrone L; Cianetti A
    Recenti Prog Med; 1990 Oct; 81(10):676-7. PubMed ID: 2291024
    [No Abstract]   [Full Text] [Related]  

  • 20. Mechanisms of action of cholecystokinin in the canine gastrointestinal tract: role of vasoactive intestinal peptide and nitric oxide.
    Vergara P; Woskowska Z; Cipris S; Fox-Threlkeld JE; Daniel EE
    J Pharmacol Exp Ther; 1996 Oct; 279(1):306-16. PubMed ID: 8859008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.